AR Inhibitors in nmCRPC: Real-World Data
Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.
Source: onclive.com
Stay updated with breaking news from Dear Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.